Page 7 - வீரியம்+மிக்கது கட்டி ஆஃப் மார்பக News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from வீரியம்+மிக்கது கட்டி ஆஃப் மார்பக. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In வீரியம்+மிக்கது கட்டி ஆஃப் மார்பக Today - Breaking & Trending Today
Synairgen plc: Synairgen announces that dosing has commenced with its inhaled interferon beta product in US Government-funded NIH ACTIV-2 trial in COVID-19 outpatients ( Synairgen or the Company ) Synairgen announces that dosing has commenced with its inhaled interferon beta product in US Government-funded NIH ACTIV-2 trial in COVID-19 outpatients Southampton, UK - 15 February 2021: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, today announces that dosing has begun in the inhaled interferon beta formulation (SNG001) sub-study of the ACTIV-2 Phase II/III trial, evaluating patients with mild to moderate COVID-19 symptoms not yet requiring hospitalisation. Richard Marsden, CEO of Synairgen, said: ....